AE37: a novel T-cell-eliciting vaccine for breast cancer

Author： Sears Alan K Perez Sonia A Clifton Guy T Benavides Linda C Gates Jeremy D Clive Kevin S Holmes Jarrod P Shumway Nathan M Van Echo David C Carmichael Mark G Ponniah Sathibalan Baxevanis Constantin N Mittendorf Elizabeth A Papamichail Michael Peoples George E

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.11, Iss.11, 2011-11, pp. : 1543-1550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD4⁺ T cells in antitumor immunity: utility of an Ii-Key HER2/neu hybrid peptide vaccine (AE37)

By Mittendorf Elizabeth A Holmes Jarrod P Murray James L von Hofe Eric Peoples George E

Expert Opinion on Biological Therapy, Vol. 9, Iss. 1, 2009-01 ,pp. : 71-78

Informa Healthcare

Access to resources Recommend Favorite

Expression of Biologically Active Human Recombinant Interferon Alpha 2b in Human Breast Cancer Cell Line Bcap-37

By Li Hui Li Xiangping Liu Qingyou Shi Zhendan Shi Deshun

Applied Biochemistry and Biotechnology, Vol. 171, Iss. 6, 2013-11 ,pp. : 1535-1544

Humana Press, Inc

Access to resources Recommend Favorite

Dendritic cell immunotherapy for breast cancer

By Pinzon-Charry Alberto Schmidt Chris López José Alejandro

Expert Opinion on Biological Therapy, Vol. 6, Iss. 6, 2006-06 ,pp. : 591-604

Informa Healthcare

Access to resources Recommend Favorite

Glycodendrimers: novel glycotope isosteres unmasking sugar coding. Case study with T-antigen markers from breast cancer MUC1 glycoprotein

By Roy R. Baek M.-G.

Reviews in Molecular Biotechnology, Vol. 90, Iss. 3, 2002-05 ,pp. : 291-309

Elsevier

Access to resources Recommend Favorite

Improving T cell therapy for cancer

By Foster Aaron E Rooney Cliona M

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 215-229

Informa Healthcare

Access to resources Recommend Favorite